Why TherapeuticsMD's Stock Jumped Today

Shares of TherapeuticsMD (NASDAQ: TXMD), a commercial-stage biopharma focused on women's health, rose 16% as of 12:50 p.m. EST on Tuesday. The bullish move is most likely linked to the news that financial giant JP Morgan (NYSE: JPM) has taken a substantial equity position in the company.

An SEC filing revealed today that JP Morgan now owns 19.7 million shares of TherapeuticsMD's common stock. That represents more than 7% of shares outstanding.

Image source: Getty Images.

Continue reading

Source Fool.com